A
lexandria Real Estate Equities (ARE) reported a third‑quarter net loss of $232.75 million, driven by a $323.9 million real‑estate impairment and lower sales and revenue versus the prior year. The company also cut its 2025 earnings outlook, citing sector headwinds, declining occupancy rates, and ongoing portfolio challenges. The impairment and guidance downgrade sharpen the focus on occupancy trends as the immediate catalyst for earnings recovery, while persistent pressure on leasing and property values remains the core risk.

    Investors considering ARE must believe in the long‑term demand for life‑science real‑estate and that the firm’s core innovation‑cluster assets can weather short‑term turbulence. The recent impairment and lower guidance reduce earnings visibility, making occupancy a key driver. Persistent vacancy and lease expirations could further erode NOI.

    ARE’s 2028 projections estimate $3.2 billion in revenue and $288.1 million in earnings, assuming a 0.7 % annual revenue decline and a $309.6 million lift from the current –$21.5 million loss. The implied fair value is $96.07 per share, representing a 65 % upside to the current price.

    Community estimates place the fair value between $71 and $136.20. Your view on sector recovery will influence how you weigh these ranges.

    A concise research snapshot highlights four potential rewards and one warning for ARE. The free report presents a visual “Snowflake” summarizing the company’s financial health at a glance.

    If you’re looking for an entry point, the current environment may be attractive. The analysis is based on historical data and analyst forecasts, using an unbiased methodology. It is not investment advice and does not reflect your personal objectives or financial situation. Simply Wall St holds no positions in the stocks discussed.